Mija Marinković

Dr. Mija Marinković

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VRVladimir Rogov
Vladimir Rogov
HSHironori Suzuki
Hironori Suzuki
MMMija Marinković
Mija Marinković
VLVerena Lang
Verena Lang
RKRyuichi Kato
Ryuichi Kato
INIvana Novak
Ivana Novak
The mitophagy receptor Nix interacts with LC3/GABARAP proteins, targeting mitochondria into autophagosomes for degradation. Here we present evidence for phosphorylation-driven regulation of the Nix:LC3B interaction. Isothermal titration calorimetry and NMR indicate a ~100 fold enhanced affinity of the serine 34/35-phosphorylated Nix LC3-interacting region (LIR) to LC3B and formation of a very rigid complex compared to the non-phosphorylated sequence. Moreover, the crystal structure of LC3B in complex with the Nix LIR peptide containing glutamic acids as phosphomimetic residues and NMR experiments revealed that LIR phosphorylation stabilizes the Nix:LC3B complex via formation of two additional hydrogen bonds between phosphorylated serines of Nix LIR and Arg11, Lys49 and Lys51 in LC3B. Substitution of Lys51 to Ala in LC3B abrogates binding of a phosphomimetic Nix mutant. Functionally, serine 34/35 phosphorylation enhances autophagosome recruitment to mitochondria in HeLa cells. Together, this study provides cellular, biochemical and biophysical evidence that phosphorylation of the LIR domain of Nix enhances mitophagy receptor engagement.

24 April 2020 in Autophagy
Verified
Journal Article
Closed access
MMMija Marinković
Mija Marinković
MŠMatilda Šprung
Matilda Šprung
INIvana Novak
Ivana Novak
Mitophagy is a conserved intracellular catabolic process responsible for the selective removal of dysfunctional or superfluous mitochondria to maintain mitochondrial quality and need in cells. Here, we examine the mechanisms of receptor-mediated mitophagy activation, with the focus on BNIP3L/NIX mitophagy receptor, proven to be indispensable for selective removal of mitochondria during the terminal differentiation of reticulocytes. The molecular mechanisms of selecting damaged mitochondria from healthy ones are still very obscure. We investigated BNIP3L dimerization as a potentially novel molecular mechanism underlying BNIP3L-dependent mitophagy. Forming stable homodimers, BNIP3L recruits autophagosomes more robustly than its monomeric form. Amino acid substitutions of key transmembrane residues of BNIP3L, BNIP3LG204A or BNIP3LG208V, led to the abolishment of dimer formation, resulting in the lower LC3A-BNIP3L recognition and subsequently lower mitophagy induction. Moreover, we identified the serine 212 as the main amino acid residue at the C-terminal of BNIP3L, which extends to the intermembrane space, responsible for dimerization. In accordance, the phosphomimetic mutation BNIP3LS212E leads to a complete loss of BNIP3L dimerization. Thus, the interplay between BNIP3L phosphorylation and dimerization indicates that the combined mechanism of LIR phosphorylation and receptor dimerization is needed for proper BNIP3L-dependent mitophagy initiation and progression. Abbreviations: AMBRA1: autophagy and beclin 1 regulator 1; Baf A1: bafilomycin A1; BH3: BCL2 homology 3; BNIP3: BCL2 interacting protein 3; BNIP3L/NIX: BCL2 interacting protein 3 like; CCCP: carbonyl cyanide 3-chlorophenylhydrazone; CoCl2: cobalt (II) chloride; FKBP8: FKBP prolyl isomerase 8; FUNDC1: FUN14 domain containing 1; GABARAP: GABA type A receptor-associated protein; GST: glutathione S-transferase; IMM: inner mitochondrial membrane; LIR: LC3-interacting region; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; OMM: outer mitochondrial membrane; PHB2: prohibitin 2; PI: propidium iodide; PINK1: PTEN induced kinase 1; TM: transmembrane domain; TOMM20: translocase of outer mitochondrial membrane 20

1 February 2003 in Carbon
Verified
Journal Article
Closed access
Zoran M. MarkovicZoran M. Markovic
Zoran M. Markovic
BMBiljana M. Todorović Marković
Biljana M. Todorović Marković
MMMija Marinković
Mija Marinković
TNT Nenadovic
T Nenadovic

28 November 2024 in Molecules
Verified
Journal Article
Open access
PDF file
IPIvana Popović
Ivana Popović
LDLucija Dončević
Lucija Dončević
RBRenata Biba
Renata Biba
KKKarla Košpić
Karla Košpić
MBMaja Barbalic
Maja Barbalic
MCMario Cindric
Mario Cindric
Adenine nucleotides (ANs)—adenosine 5′-triphosphate (ATP), adenosine 5′-diphosphate (ADP), and adenosine 5′-monophosphate (AMP)—are essential for energy transfer and the supply of countless processes within cellular metabolism. Their concentrations can be expressed as adenylate energy charge (AEC), a measure of cellular metabolic energy that directly correlates with the homeostasis of the organism. AEC index has broad diagnostic potential, as reduced ATP levels are associated to various conditions, such as inflammatory diseases, metabolic disorders, and cancer. We introduce a novel methodology for rapid isolation, purification, and quantification of ANs from a single drop of capillary blood. Of all the stationary phases tested, activated carbon proved to be the most efficient for the purification of adenine nucleotides, using an automated micro-solid phase extraction (µ-SPE) platform. An optimized µ-SPE method, coupled with RP-HPLC and a run time of 30 min, provides a reliable analytical framework for adenine nucleotide analysis of diverse biological samples. AN concentrations measured in capillary blood samples were 1393.1 µM, 254.8 µM, and 76.9 µM for ATP, ADP, and AMP molecules aligning with values reported in the literature. Overall, this study presents a streamlined and precise approach for analyzing ANs from microliters of blood, offering promising applications in clinical diagnostics.

23 December 2024 in FEBS Open Bio
Verified
Journal Article
Open access
MMMija Marinković
Mija Marinković
ARAna Rožić
Ana Rožić
DPDenis Polančec
Denis Polančec
INIvana Novak
Ivana Novak
Mitophagy, a selective clearance of damaged or superfluous mitochondria via autophagy machinery and lysosomal degradation, is an evolutionarily conserved process essential for various physiological functions, including cellular differentiation and immune responses. Defects in mitophagy are implicated in numerous human diseases, such as neurodegenerative disorders, cancer, and metabolic conditions. Despite significant advancements in mitophagy research over recent decades, novel and robust methodologies are necessary to elucidate its molecular mechanisms comprehensively. In this study, we present a detailed protocol for quantitatively assessing mitophagy through flow cytometry using a mitochondria‐targeted fluorescent mitophagy receptor, GFP‐BNIP3L/NIX. This method offers a rapid alternative to conventional microscopy or immunoblotting techniques for analyzing mitophagy activity. Additionally, this approach can theoretically be adapted to utilize any fluorescent‐tagged selective autophagy receptor, enabling the direct and rapid analysis of various types of receptor‐mediated selective autophagy.

20 August 2026
Verified
Book Chapter
Open access
PDF file
IPIvana Popović
Ivana Popović
ARAna Rožić
Ana Rožić
TMTina Milardović
Tina Milardović
MMMija Marinković
Mija Marinković
Autophagy is a fundamental intracellular pathway responsible for maintaining cellular homeostasis under both physiological and stress conditions. Through the degradation of damaged proteins and organelles and the recycling of intracellular material, it contributes to cellular adaptation and preservation of cellular function. In addition, autophagy interacts with multiple forms of regulated cell death (RCD) and influences processes associated with cell survival and cell death. These interactions involve signaling networks that respond to metabolic changes, oxidative damage, and environmental challenges. This chapter describes the molecular basis of autophagy and discusses its contribution to cellular function under physiological and stress conditions. Interactions between autophagy and RCD pathways, including apoptosis, ferroptosis, necroptosis, and pyroptosis, are also addressed. Cancer is discussed as an example that illustrates how the consequences of autophagy can vary according to biological context. While autophagy may restrict early tumor development, it can also support the survival and progression of established tumors. This chapter further considers the use of autophagy modulation in therapeutic strategies. Together, these topics provide an overview of the involvement of autophagy in cellular physiology, disease, and RCD.